Nicola Stagg, based in Oakland, CA, US, is currently a Executive Director, Head of Toxicology at Turning Point Therapeutics, bringing experience from previous roles at Tp Therapeutics, Inc. and Genentech. Nicola Stagg holds a 2003 - 2007 Doctor of Philosophy in Toxicology, Pharmacology @ University of Arizona. With a robust skill set that includes Biotechnology, Biochemistry, Regulatory Affairs, Drug Development, CRO and more, Nicola Stagg contributes valuable insights to the industry. Nicola Stagg has 3 emails on RocketReach.